On March 21, 2024, Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD cancelled the transaction. The transaction has been approved in the third meeting of the fifth board of directors and the second meeting of the fifth board of supervisors. The company also received Application for Issuing Stocks to Specific Targets issued by Shenzhen Stock Exchange (Shenzhen Stock Exchange [2024] No.

59.